Multiple companies.
Shared intelligence.
One ecosystem.
Independent companies with specialized expertise, brought together in one ecosystem where technology, intelligence, and creativity converge.
A company specializing in advanced technology solutions and digital signage.
A software company powered by AI architects.
IOT Solutions, with a direct focus on innovation and generation of solutions for the tourism, gastronomic and pharmaceutical sectors.
Communication and PR company that, from a different perspective, tells and creates stories that go together with projects that start from an illusion.
Aging is an intrinsically complex systems biology challenge. Our Integrated Platform is purpose-built to unravel its intricate networks.
Synthetic Biology Control
Using light-activated molecular switches to perturb cellular systems with millisecond optical precision and high spatial resolution.
Machine Learning Discovery
Deep Learning models trained on multimodal single-cell data to predict compound efficacy against complex cellular aging hallmarks.
Targeted Senotherapeutics
Selective clearance of senescent cell populations without damaging surrounding healthy tissue matrix.
TIME IS YOURS AGAIN
BUILDING LITTLE THINKERS
WHERE GIFTING GETS SOCIAL
We believe in building a better society, is one of our main pillars. The Papaya Group, as promoter of the Scholas Labs program, collaborates with Scholas Occurrentes international foundation of Pope Francis, which promotes the integration and educational improvement of young people.
VISIT WEBSITE
Latest Publications & Press
Discovering Novel Senolytics Using AI and High-Throughput Synthetic Biology
Demonstrating deep learning models capable of identifying small molecule therapeutics targeting cellular senescence with 80% higher specificity.
Optogenetic Control of Mammalian Stress Pathways for Drug Screening
A platform for real-time optical modulation of intracellular pathways to quantify compound anti-aging efficacy in vitro.
Integrated Biosciences Secures Series A to Advance Longevity Pipeline
Accelerating clinical development of AI-discovered small molecules targeting age-related neurodegeneration and fibrosis.